Machine perfusion for cardiac allograft preservation

被引:36
作者
Cobert, Michael L. [1 ]
West, LaShondra M. [1 ]
Jessen, Michael E. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA
关键词
heart transplantation; machine perfusion; myocardial ischermia; myocardial preservation; organ preservation;
D O I
10.1097/MOT.0b013e32830fdf9a
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review The current cardiac preservation strategy for cardiac transplantation involves arresting hearts with a crystalloid preservation solution and storing them in this solution in an ice chest. This technique has allowed good results in heart transplantation, but has limited the transport interval, and has not encouraged major efforts to expand the donor pool. Machine perfusion of explanted organs, a technique used clinically in kidney transplantation, is now under active investigation in the cardiac arena. This review examines the current status of this technology. Recent findings Recent experimental studies in animals have tested machine perfusion for cardiac preservation. This technique appears to reduce the allograft ischemic burden, may permit longer preservation times, and improves early ventricular function upon reperfusion of the donor heart. The metabolic profile of the stored heart appears better preserved with machine perfusion; however, investigators have noted a risk of edema development in perfused cardiac grafts. Summary Early experimental results are encouraging and suggest that machine perfusion may offer superior cardiac performance after transplantation. In the future, this technology may lead to an expansion of the donor pool through greater use of expanded-criteria donors, resuscitation of ischemically injured hearts, or procurement of hearts that are donated after cardiac death.
引用
收藏
页码:526 / 530
页数:5
相关论文
共 59 条
[1]   Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: Role of purine release in ischemic and reperfusion injury [J].
Abd-Elfattah, AS ;
Jessen, ME ;
Lekven, J ;
Wechsler, AS .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 180 (1-2) :179-191
[2]  
ABDELFATTAH AS, 1988, CIRCULATION, V78, P224
[3]   New directions in cardiac transplantation [J].
Al-Khaldi, A ;
Robbins, RC .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :455-471
[4]  
BARNARD C N, 1967, South African Medical Journal, V41, P1271
[5]   SUCCESSFUL 17-HOUR PRESERVATION AND TRANSPLANTATION OF HUMAN-CADAVER KIDNEY [J].
BELZER, FO ;
ASHBY, BS ;
GULYASSY, PF ;
POWELL, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (11) :608-&
[6]   National impact of pulsatile perfusion on cadaveric kidney transplantation [J].
Burdick, JF ;
Rosendale, JD ;
McBride, MA ;
Kauffman, HM ;
Bennett, LE .
TRANSPLANTATION, 1997, 64 (12) :1730-1733
[7]   Twelve-hour canine heart preservation with a simple, portable hypothermic organ perfusion device [J].
Calhoon, JH ;
Bunegin, L ;
Gelineau, JF ;
Felger, MC ;
Naples, JJ ;
Miller, OL ;
Sako, EY .
ANNALS OF THORACIC SURGERY, 1996, 62 (01) :91-93
[8]   Use of diffusion tensor imaging to predict myocardial viability after warm global ischemia: Possible avenue for use of non-beating donor hearts [J].
Collins, Michael J. ;
Ozeki, Toshinaga ;
Zhuo, Jiachen ;
Gu, Junyan ;
Gullapalli, Rao ;
Pierson, Richard N. ;
Griffith, Bartley P. ;
Fedak, Paul W. M. ;
Poston, Robert S. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (04) :376-383
[9]   IN-VITRO PRESERVATION OF CANINE HEARTS FOR 24 TO 28 HOURS FOLLOWED BY SUCCESSFUL ORTHOTOPIC TRANSPLANTATION [J].
COPELAND, JG ;
JONES, M ;
SPRAGG, R ;
STINSON, EB .
ANNALS OF SURGERY, 1973, 178 (06) :687-692
[10]   Outcomes with an alternate list strategy for heart transplantation [J].
Felker, GM ;
Milano, CA ;
Yager, JEE ;
Hernandez, AF ;
Blue, L ;
Higginbotham, MB ;
Lodge, AJ ;
Russell, SD .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11) :1781-1786